You can enable subtitles (captions) in the video player
And so let's move on to the vaccine. There's obviously been hopes riding high for a vaccine to be approved before the election. You told my colleague, Kiran Stacey, at the FT that it could be, but not because Trump wants it. When do you now expect it?
So I've said previously, and I'll say again, Hannah, I can't tell you when a vaccine will be available. Because as you know, an application has to be sent to us. And that application will be sent to us when the sponsors, when the manufacturers, determine that the data from their clinical trials are mature.
Now, FDA, on June 30, issued guidance that stated what criteria in general we'd be looking at in order to make a decision about safety and efficacy. We've continued to have conversations with our sponsors regarding those data. We spoke to the safety and efficacy data that we would need to see. So when the sponsor feels that those data are mature from the clinical trials, they will submit an application to us. At that time, we will apply the standards that we've stated to look at those data, and we'll make a decision
I'm a cancer doctor, Hannah. I told patients for years, I don't have a crystal ball. And I don't have a crystal ball here either.
When the data are ready, we will look at those data, and our folks will make a decision. And as you know, we plan to use the vaccine advisory committee to also help us look at these data and to provide advice regarding those data to inform our decision around safety and effectiveness. We won't cut corners. We will use our rigorous criteria.
